# Enanta Pharmaceuticals Inc: Form 8-K, filed May 6, 2024

- Company: [Enanta Pharmaceuticals Inc](/companies/enta.md) (CIK 1177648)
- Form: 8-K
- Filed: 2024-05-06
- Accepted by EDGAR: May 6, 2024, 16:05 ET
- Period: 2024-05-06
- Accession: 0000950170-24-053532
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1177648/000095017024053532/enta-20240506.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1177648/000095017024053532/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1177648/000095017024053532/enta-20240506.htm

Filed May 6, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-053532. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.